Fibrofatty changes in failed pediatric cardiac allografts

Area of Science:

• Cardiology
• Transplantation Immunology
• Pathology

Background:

• Right ventricular fibrofatty changes are associated with arrhythmogenic right ventricular dysplasia, a genetic cardiomyopathy.
• Fibrofatty changes can also be acquired due to inflammation, ischemia, or aging.
• The presence and significance of fibrofatty changes in pediatric cardiac allografts were previously unclear.

Purpose of the Study:

• To investigate the prevalence and clinical implications of right ventricular fibrofatty changes in failed pediatric cardiac allografts.
• To determine if these changes are associated with graft failure and compare them to arrhythmogenic right ventricular dysplasia.

Main Methods:

• Retrospective analysis of 29 failed pediatric cardiac allografts.
• Histopathological examination of right ventricular tissue to assess fibrofatty changes.
• Comparison of clinical parameters and transplant outcomes between patients with and without severe fibrofatty changes.

Main Results:

• Severe right ventricular fibrofatty changes were identified in 13% of failed allografts.
• Patients with fibrofatty changes experienced significantly shorter graft survival (2.75 years vs. 5.45 years).
• No significant differences in physiological parameters or arrhythmias suggestive of arrhythmogenic right ventricular dysplasia were found.

Conclusions:

• Fibrofatty infiltration in pediatric cardiac allografts is a distinct entity from arrhythmogenic right ventricular dysplasia.
• The presence of fibrofatty infiltrates may predict shortened pediatric cardiac allograft survival.
• Routine right ventricular biopsy may help identify this predictive factor for improved transplant management.